NDC 63629-9715-01 - Sulfasalazine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-9715
- Requested NDC
- 63629-9715-01
- Package NDCs from labels
- 63629-9715-1, 63629-9715-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-04-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sulfasalazine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-04-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-9715-1 | Sulfasalazine | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-9715 | SULFASALAZINE TABLET [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20240509_618c5324-d0a6-4d00-9b12-0de88a71c180.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfasalazine | SULFASALAZINE | Mylan Pharmaceuticals Inc. | 257cee60-b68f-4c2b-b57d-8e4d73d17e09 | 2026-08-25 | Warnings, Adverse reactions | 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | Mylan Pharmaceuticals Inc. | 48fbc535-a33a-45ee-85ff-9d1ec9b31d9c | 2026-08-25 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Azulfidine | SULFASALAZINE | Pfizer Laboratories Div Pfizer Inc | ddbe69f3-bd55-45f3-a64f-f60226c744c4 | 2026-05-29 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Azulfidine EN-tabs | SULFASALAZINE | Pfizer Laboratories Div Pfizer Inc | b9ef541a-93c8-4428-ba45-398aa0b327d1 | 2026-05-29 | Warnings, Adverse reactions | 3XC8GUZ6CB |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Sulfasalazine | SULFASALAZINE | Sunrise Pharmaceutical, Inc. | d596ac59-b643-4181-80ba-f2db1cc3459c | 2025-12-11 | Warnings, Adverse reactions | 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | Rising Pharma Holdings, Inc. | 3254432e-87a4-4af0-afd1-d9e6f1b0efd4 | 2025-11-06 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | Sunrise Pharmaceutical, Inc. | a54b31cc-205d-43d3-a850-acf4b41fbc37 | 2025-09-15 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | A-S Medication Solutions | 76b532a3-e7ca-4929-8c51-c0f66e0806a8 | 2025-04-08 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | A-S Medication Solutions | 32fd1726-ed81-4441-9594-3aecf2db1dbf | 2025-04-08 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | Bryant Ranch Prepack | 618c5324-d0a6-4d00-9b12-0de88a71c180 | 2024-04-04 | Warnings, Adverse reactions | ANDA085828 63629-9715-1 63629-9715 63629971501 198232 00104d3b-3b62-49fb-8a04-26ec7c24efcc 618c5324-d0a6-4d00-9b12-0de88a71c180 3XC8GUZ6CB |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 4ELV7Z65AP |
| Sulfasalazine | SULFASALAZINE | Teva Pharmaceuticals USA, Inc. | 3c59593b-e1a5-47cb-a82b-3e5e49205344 | 2023-08-22 | Warnings, Adverse reactions | ANDA085828 0093-3234 198232 6bb77fd9-0f19-4f91-8eb9-33d9c6b5c471 3c59593b-e1a5-47cb-a82b-3e5e49205344 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | Aphena Pharma Solutions - Tennessee, LLC | bf5137fe-60ed-4497-8521-eeb0a684fabf | 2023-05-16 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
| Sulfasalazine | SULFASALAZINE | Chartwell RX, LLC. | 029716bd-ee1a-484c-bf1f-ec8d02d5281b | 2022-12-12 | Warnings, Adverse reactions | 198232 3XC8GUZ6CB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.